feed,title,long_url,short_url
SeekingAlpha,Provention Bio price target lowered at Cantor assuming a delay in teplizumab launch,https://seekingalpha.com/news/3693565,
SeekingAlpha,SPAC Acon S2 rises slightly on deal to take battery firm ESS public at $1.1B valuation,https://seekingalpha.com/news/3693564,
